|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
-33.33% | -83.33% |
| Market Cap | 1.19M 840K 735K 674K 630K 80M 1.21M 8.11M 3.15M 39.35M 3.16M 3.09M 136M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 470K 331K 290K 266K 248K 31.52M 478K 3.19M 1.24M 15.5M 1.24M 1.22M 53.45M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -33.33% | ||
| 1 month | -33.33% | ||
| 3 months | -50.00% | ||
| 6 months | -83.33% | ||
| Current year | -83.33% |
| 1 week | 0 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.25 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 0.85 |
| 10 years | 0 | | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 2019-09-30 |
José Roldan
DFI | Director of Finance/CFO | - | 2022-12-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 2019-09-30 |
Daniel Augereau
BRD | Director/Board Member | 82 | 2019-09-30 |
Eric Klein
BRD | Director/Board Member | 66 | 2019-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-06-01 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 25-03-20 | Buy | Chief Executive Officer | 100,000 | 0.0838% | ||
| 25-03-20 | Buy | Chief Executive Officer | 200,000 | 0.1675% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -33.33% | 0.00% | -85.71% | 841K | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +32.57% | +24.89% | 338B | |
| -0.56% | +0.96% | +41.67% | +39.35% | 299B | |
| -0.08% | +1.30% | +32.15% | +44.48% | 291B | |
| -1.54% | +2.81% | -25.35% | -39.61% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.89% | +4.12% | +28.60% | +43.83% | 369.24B | |
| Weighted average by Cap. | +2.25% | +5.53% | +42.31% | +83.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.06M 2.67M 2.45M 2.29M 291M 4.41M 29.49M 11.45M 143M 11.48M 11.23M 493M | 3.36M 2.37M 2.07M 1.9M 1.77M 225M 3.41M 22.82M 8.86M 111M 8.89M 8.69M 382M |
| Net income | -16.5M -11.61M -10.17M -9.32M -8.71M -1.11B -16.76M -112M -43.5M -544M -43.64M -42.69M -1.88B | -8.91M -6.27M -5.49M -5.03M -4.7M -597M -9.05M -60.51M -23.49M -294M -23.56M -23.05M -1.01B |
| Net Debt | -626K -440K -385K -353K -330K -41.93M -636K -4.25M -1.65M -20.62M -1.65M -1.62M -71.1M | -723K -509K -446K -409K -382K -48.48M -735K -4.91M -1.91M -23.85M -1.91M -1.87M -82.21M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | $0.0100 | 0.00% | 1,000 |
| 26-06-30 | $0.0100 | 0.00% | 65,000 |
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
